Skip to main content
SpringerLink
Log in

Stomach Duodenum Nuclear Medicine

  • Reference work entry
Abdominal Imaging

  • 432 Accesses

Abstract

Positron emission tomography (PET) is a molecular imaging modality used to evaluate a wide variety of neoplasms, particularly for staging, follow-up, therapy stratification, and monitoring. As PET imaging is based mainly on the physiological distribution of the administered radiotracer, the addition of computed tomography (CT) to PET allows for more accurate localization of PET findings as well as providing additional morphological information which may be complementary in lesion characterization. Furthermore, CT allows for the generation of highly accurate attenuation maps for PET attenuation correction, yielding a significant increase in image quality.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 1,099.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 1,599.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Agaimy A, Markl B, Arnholdt H, et al. Multiple sporadic gastrointestinal stromal tumors arising at different gastrointestinal sites: pattern of involvement of the muscularis propria as a clue to independent primary GISTs. Virchows Arch. 2009;455(2):101–8.

    Article  PubMed  CAS  Google Scholar 

  • Alakus H, Batur M, Schmidt M, Drebber U, Baldus SE, Vallböhmer D, et al. Variable 18F-fluorodeoxyglucose uptake in gastric cancer is associated with different levels of GLUT-1 expression. Nucl Med Commun. 2010;31:532–8.

    PubMed  CAS  Google Scholar 

  • Ambrosini V, Campana D, Bodei L, Nanni C, Castellucci P, Allegri V, Montini GC, Tomassetti P, Paganelli G, Fanti S. 68Ga-DOTANOC PET/CT clinical impact in patients with neuroendocrine tumors. J Nucl Med. 2010;51:669–73.

    Article  PubMed  Google Scholar 

  • Campana D, Nori F, Piscitelli L, Morselli-Labate AM, Pezzilli R, Corinaldesi R, Tomassetti P, Chromogranin A. Is it a useful marker of neuroendocrine tumors? J Clin Oncol. 2007;25:1967–73.

    Article  PubMed  CAS  Google Scholar 

  • Choi H, Charnsangavej C, de Castro Faria S, et al. CT evaluation of the response of gastrointestinal stromal tumors after imatinib mesylate treatment: a quantitative analysis correlated with FDG PET findings. AJR Am J Roentgenol. 2004;183:1619–28.

    Article  PubMed  Google Scholar 

  • Demetri GD, von Mehren M, Antonescu CR, DeMatteo RP, Ganjoo KN, Maki RG, Pisters PW, Raut CP, Riedel RF, Schuetze S, Sundar HM, Trent JC, Wayne JD. NCCN task force report: update on the management of patients with gastrointestinal stromal tumors. J Natl Compr Canc Netw. 2010;8(Suppl 2):S1–41. quiz S42-4.

    PubMed  CAS  Google Scholar 

  • Fletcher CD, Berman JJ, Corless C, et al. Diagnosis of gastrointestinal stromal tumors: a consensus approach. Int J Surg Pathol. 2002;10(2):81–9.

    Article  PubMed  Google Scholar 

  • Gabriel M, Decristoforo C, Kendler D, Dobrozemsky G, Heute D, Uprimny C, Kovacs P, Von Guggenberg E, Bale R, Virgolini IJ. 68Ga-DOTA-Tyr3-octreotide PET in neuroendocrine tumors: comparison with somatostatin receptor scintigraphy and CT. J Nucl Med. 2007;48(4):508–18.

    Article  PubMed  CAS  Google Scholar 

  • Habermann CR, Weiss F, Riecken R, et al. Preoperative staging of gastric adenocarcinoma: comparison of helical CT and endoscopic US. Radiology. 2004;230:465–71.

    Article  PubMed  Google Scholar 

  • Haug A, Auernhammer CJ, Wängler B, Tiling R, Schmidt G, Göke B, Bartenstein P, Pöpperl G. Intraindividual comparison of 68Ga-DOTA-TATE and 18F-DOPA PET in patients with well-differentiated metastatic neuroendocrine tumors. Eur J Nucl Med Mol Imaging. 2009;36:765–70.

    Article  PubMed  CAS  Google Scholar 

  • Heinrich MC, Corless CL, Duensing A, et al. PDGFRA-activating mutations in gastrointestinal stromal tumors. Science. 2003;299(5607):708–10.

    Article  PubMed  CAS  Google Scholar 

  • Heusner TA, Hahn S, Hamami ME, Kim UH, Baumeister R, Forsting M, et al. Gastrointestinal 18F-FDG accumulation on PET without a corresponding CT abnormality is not an early indicator of cancer development. Eur Radiol. 2009;19:2171–9.

    Article  PubMed  Google Scholar 

  • Hillner BE, Siegel BA, Shields AF, Liu D, Gareen IF, Hunt E, et al. Relationship between cancer type and impact of PET and PET/CT on intended management: findings of the National Oncologic PET Registry. J Nucl Med. 2008;49:1928–35.

    Article  PubMed  Google Scholar 

  • Hirota S, Isozaki K, Moriyama Y, et al. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science. 1998;279(5350):577–80.

    Article  PubMed  CAS  Google Scholar 

  • Kawamura T, Kusakabe T, Sugino T, Watanabe K, Fukuda T, Nashimoto A, et al. Expression of glucose transporter-1 in human gastric carcinoma: association with tumor aggressiveness, metastasis, and patient survival. Cancer. 2001;92:634–41.

    Article  PubMed  CAS  Google Scholar 

  • Kim SK, Kang KW, Lee JS, Kim HK, Chang HJ, Choi JY, et al. Assessment of lymph node metastases using 18F-FDG PET in patients with advanced gastric cancer. Eur J Nucl Med Mol Imaging. 2006;33:148–55.

    Article  PubMed  Google Scholar 

  • Koopmans KP, de Vries EG, Kema IP, Elsinga PH, Neels OC, Sluiter WJ, van der Horst-Schrivers AN, Jager PL. Staging of carcinoid tumors with 18F-DOPA PET: a prospective, diagnostic accuracy study. Lancet Oncol. 2006;7:728–34.

    Article  PubMed  CAS  Google Scholar 

  • Krenning EP, Valkema R, Kwekkeboom DJ, de Herder WW, van Eijck CH, de Jong M, Pauwels S, Reubi JC. Molecular imaging as in vivo molecular pathology for gastroenteropancreatic neuroendocrine tumors: implications for follow-up after therapy. J Nucl Med. 2005;46(Suppl 1):76S–82.

    PubMed  Google Scholar 

  • Kwee RM, Kwee TC. Imaging in assessing lymph node status in gastric cancer. Gastric Cancer. 2009;12:6–22. Review.

    Article  PubMed  CAS  Google Scholar 

  • Kwekkeboom DJ, Krenning EP, Bakker WH, Oei HY, Kooij PP, Lamberts SW. Somatostatin analogue scintigraphy in carcinoid tumors. Eur J Nucl Med. 1993;20:283–92.

    Article  PubMed  CAS  Google Scholar 

  • Lerut T, Flamen P, Ectors N, Van Cutsem E, Peeters M, Hiele M, et al. Histopathologic validation of lymph node staging with FDG-PET scan in cancer of the esophagus and gastroesophageal junction: a prospective study based on primary surgery with extensive lymphadenectomy. Ann Surg. 2000;232:743–52.

    Article  PubMed  CAS  Google Scholar 

  • Levy AD, Remotti HE, Thompson WM, Sobin LH, Miettinen M. Gastrointestinal stromal tumors: radiologic features with pathologic correlation. Radiographics. 2003;23(2):283–304.

    Article  PubMed  Google Scholar 

  • Lim JS, Kim MJ, Yun MJ, Oh YT, Kim JH, Hwang HS, et al. Comparison of CT and 18F-FDG PET for detecting peritoneal metastasis on the preoperative evaluation for gastric carcinoma. Korean J Radiol. 2006;7:249–56.

    Article  PubMed  Google Scholar 

  • Miettinen M, Sobin LH, Lasota J. Gastrointestinal stromal tumors of the stomach: a clinicopathologic, immunohistochemical, and molecular genetic study of 1,765 cases with long-term follow-up. Am J Surg Pathol. 2005;29(1):52–68.

    Article  PubMed  Google Scholar 

  • Mukai K, Ishida Y, Okajima K, Isozaki H, Morimoto T, Nishiyama S. Usefulness of preoperative FDG-PET for detection of gastric cancer. Gastric Cancer. 2006;9:192–6.

    Article  PubMed  Google Scholar 

  • Podoloff DA, Ball DW, Ben-Josef E, Benson 3rd AB, Cohen SJ, Coleman RE, et al. NCCN task force: clinical utility of PET in a variety of tumor types. J Natl Compr Canc Netw. 2009;7(Suppl 2):S1–26. Review.

    PubMed  Google Scholar 

  • Radan L, Fischer D, Bar-Shalom R, Dann EJ, Epelbaum R, Haim N, Gaitini D, Israel O. FDG avidity and PET/CT patterns in primary gastric lymphoma. Eur J Nucl Med Mol Imaging. 2008;35(8):1424–30.

    Article  PubMed  Google Scholar 

  • Rindi G, Klöppel G, Couvelard A, Komminoth P, Körner M, Lopes JM, McNicol AM, Nilsson O, Perren A, Scarpa A, et al. TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system. Virchows Arch. 2007;451:757–62.

    Article  PubMed  CAS  Google Scholar 

  • Solcia E, Kloppel G, Sobin LH. Histological typing of endocrine tumors. World Health Organization international histological classification of tumours. 2nd ed. Berlin: Springer; 2000.

    Book  Google Scholar 

  • Stahl A, Ott K, Weber WA, Becker K, Link T, Siewert JR, et al. FDG PET imaging of locally advanced gastric carcinomas: correlation with endoscopic and histopathological findings. Eur J Nucl Med Mol Imaging. 2003;30:288–95.

    Article  PubMed  CAS  Google Scholar 

  • Sun L, Su XH, Guan YS, Pan WM, Luo ZM, Wei JH, et al. Clinical role of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in post-operative follow up of gastric cancer: initial results. World J Gastroenterol. 2008;14:4627–32.

    Article  PubMed  Google Scholar 

  • Takahashi H, Ukawa K, Ohkawa N, Kato K, Hayashi Y, Yoshimoto K, et al. Significance of (18)F-2-deoxy-2-fluoro-glucose accumulation in the stomach on positron emission tomography. Ann Nucl Med. 2009;23:391–7.

    Article  PubMed  Google Scholar 

  • Taniyama Y, Suzuki T, Mikami Y, Moriya T, Satomi S, Sasano H. Systemic distribution of somatostatin receptor subtypes in human: an immunohistochemical study. Endocr J. 2005;52:605–11.

    Article  PubMed  CAS  Google Scholar 

  • Tsujimoto H, Sugasawa H, Ono S, Ichikura T, Yamamoto J, Hase K. Has the accuracy of preoperative diagnosis improved in cases of early-stage gastric cancer? World J Surg. 2010;34:1840–6.

    Article  PubMed  Google Scholar 

  • Wahl RL, Jacene H, Kasamon Y, Lodge MA. From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumors. J Nucl Med. 2009;50(Suppl 1):122S–50. Review.

    Article  PubMed  CAS  Google Scholar 

  • Wong WL, Chambers RJ. Role of PET/PET CT in the staging and restaging of thoracic oesophageal cancer and gastro-oesophageal cancer: a literature review. Abdom Imaging. 2008;33:183–90. Review.

    Article  PubMed  Google Scholar 

  • Yamada A, Oguchi K, Fukushima M, Imai Y, Kadoya M. Evaluation of 2-deoxy-2-[18F] fluoro-d-glucose positron emission tomography in gastric carcinoma: relation to histological subtypes, depth of tumor invasion, and glucose transporter-1 expression. Ann Nucl Med. 2006;20:597–604.

    Article  PubMed  CAS  Google Scholar 

  • Yoshioka T, Yamaguchi K, Kubota K, Saginoya T, Yamazaki T, Ido T, et al. Evaluation of 18F-FDG PET in patients with advanced, metastatic, or recurrent gastric cancer. J Nucl Med. 2003;44:690–9.

    PubMed  CAS  Google Scholar 

  • Zhu Z, Li F, Mao Y, Cheng W, Cheng X, Dang Y. Improving evaluation of primary gastric malignancies by distending the stomach with milk immediately before 18F-FDG PET scanning. J Nucl Med Technol. 2008;36:25–9.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medical Radiology, University Hospital Zürich, Raemistrasse 100, Zürich, 8091, Switzerland

    Junior Staff David W. Crook

  2. Department of Medical Radiology and Director Nuclear Medicine, University Hospital Zürich, Raemistrasse 100, Zürich, 8091, Switzerland

    Professor and Chairman Gustav K. von Schulthess MD, PhD, MD hon (Professor and Chairman)

Authors
  1. Junior Staff David W. Crook
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Professor and Chairman Gustav K. von Schulthess MD, PhD, MD hon
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to David W. Crook .

Editor information

Editors and Affiliations

  1. Department of Radiology, Charité - Universitätsmedizin Berlin, Berlin, Germany

    Bernd Hamm

  2. Department of Radiology, Case Western Reserve University, University Hospitals Case Medical Center, Cleveland, OH, USA

    Pablo R. Ros

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer-Verlag Berlin Heidelberg

About this entry

Cite this entry

Crook, D.W., von Schulthess, G.K. (2013). Stomach Duodenum Nuclear Medicine. In: Hamm, B., Ros, P.R. (eds) Abdominal Imaging. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-13327-5_15

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-13327-5_15

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-13326-8

  • Online ISBN: 978-3-642-13327-5

  • eBook Packages: MedicineReference Module Medicine

Publish with us

Policies and ethics

Search

Navigation